Dynamic modeling of cancer signaling for precision medicine: a QBI/SBI Seminar with Dirk Fey

The QBI/SBI Seminar Series on molecular networks of cancer and other diseases aims to facilitate collaborative relationships between scientists from both the US and Ireland. QBI and UCD recently signed a five-year memorandum of understanding (MOU) to reinforce the links between scientists in San Francisco and Dublin, and enhance their collaborative ability to strengthen scientific research and innovation. Through this agreement, scientists will work together to identify opportunities to promote cooperative biosciences research and training activities.

On November 9, the series will present Dirk Fey, an Ad Astra Assistant Professor for Anatomy at the School of Medicine of University College Dublin, who leads the Cancer Dynamics and Modeling group in Systems Biology Ireland. His aim is a quantitative understanding of cancer related signaling networks across the scales ranging from the intracellular to the organism level. He holds a PhD with “European” distinction from the University of Liege, Belgium, and a MEng in Engineering Cybernetics from the University of Stuttgart. Dirk’s career path included industry and several academic institutions, including BASF Ludwigshafen and Thomas Jefferson University, Philadelphia. He has won several scientific prizes, including the Irish Laboratory Award 2017 for Collaboration Achievement.